The DOI matches its Crossref record; 0 of the 1 references it cites were found in a registry or an index.
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Abstract
Bacterial infection of the mammalian bloodstream can lead to overwhelming sepsis, a potentially fatal syndrome of irreversible cardiovascular collapse (shock) and critical organ failure. Cachectin, also known as tumour necrosis factor, is a macrophage-derived peptide hormone released in response to bacterial lipopolysaccharide, and it has been implicated as a principal mediator of endotoxic shock, although its function in bacterial sepsis is not known. Anaesthetized baboons were passively immunized against endogenous cachectin and subsequently infused with an LD100 dose of live Escherichia coli. Control animals (not immunized against cachectin) developed hypotension followed by lethal renal and pulmonary failure. Neutralizing monoclonal anti-cachectin antibody fragments (F(ab')2) administered to baboons only one hour before bacterial challenge protected against shock, but did not prevent critical organ failure. Complete protection against shock, vital organ dysfunction, persistent stress hormone release and death was conferred by administration of antibodies 2 h before bacterial infusion. These results indicate that cachectin is a mediator of fatal bacteraemic shock, and suggest that antibodies against cachectin offer a potential therapy of life-threatening infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF is produced during Gram-negative bacteria-induced acute septic shock (3).”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [3]
In the citing paper
“Consider as one example the case of TNF, a cytokine implicated as a necessary and sufficient mediator of lethal septic shock caused by infection with Gram-negative bacteria.”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [3]
Citations
Cites
1. Kreger, B. E. W., Craven, D. E. & McCabe, W. R. Am. J. Med. 68, 344-355 (1980). 2. Ziegler, E. J. el al New Engl. J. Med, 307, 1225-1230 (1982). 3. Gilbert, R. P. Physiol. Rev. 40, 245-279 (1960). 4. Beutler, B. & Cerami, A. Nature 320, 584-588 (1986). 5. Beutler, B. & Cerami, A. New Engl. J. Med
(n.d.)
Unresolved
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Necrotizing Enterocolitis of the Newborn: Pathogenetic Concepts in Perspective
Hsueh, W., Caplan, M. S., Tan, X., MacKendrick, W., & González-Crussí, F. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900002 · Cited by 53
“LPS induces endogenous TNF production [36,41,42] and administration of TNF causes shock [43,44], whereas pretreatment of the animal with anti-TNF [44] ameliorates endotoxin shock and increases survival.”
Uchikura, K., Wada, T., Hoshino, S., Nagakawa, Y., Aiko, T., Bulkley, G. B., Klein, A. S., & Sun, Z. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00314.2003 · Cited by 54
Gröne, A., Frisk, A.-L., & Baumgärtner, W. (1998) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(98)00170-6 · Cited by 54
Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease
Mancuso, G., Tomasello, F., Migliardo, M., Delfino, D., Cochran, J., Cook, J., & Teti, G. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.4997-5002.1994 · Cited by 63
“In some gram-positive and gram-negative bacterial sepsis models, lethality and pathophysiologic changes are mediated by TNF-o (10, 33) and IL-1 (2, 25).”
BackgroundJeschke, M. G., Barrow, R. E., Suzuki, F., Rai, J., Benjamin, D., & Herndon, D. N. (2002) · Molecular Medicine · doi:10.1007/bf03402149 · Cited by 54
“sults in vitro and in animal models by increasing survival rates in the state of septicemia ( 2 ,24,25).”
BackgroundTumor Necrosis Factor Mediates Impaired Wound Healing in Chronic Abdominal Sepsis
Cooney, R. N., Iocono, J. A., Maish, G. O., Smith, J. S., & Ehrlich, P. (1997) · doi:10.1097/00005373-199703000-00008 · Cited by 54
Yu, C., Chang, K., Chiu, C.-J., et al. (1989) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748909099924 · Cited by 54
Block, M. I., van den Berg, M. J. W., McNamara, M. J., Norton, J. A., Fraker, D. L., & Alexander, H. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1085 · Cited by 53
“production of other mediators (IL-1 and IL-6) (33-35).”
BackgroundThe pathophysiology of advanced heart failure
Baig, M. K., Mahon, N., McKenna, W. J., Caforio, A. L. P., Bonow, R. O., Francis, G. S., & Gheorghiade, M. (1999) · Heart & Lung · doi:10.1053/hl.1999.v28.a97762 · Cited by 63
Palmer, C. D., Mancuso, C. J., Weiss, J. P., Serhan, C. N., Guinan, E. C., & Levy, O. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311145 · Cited by 56
“GNB/endotoxemia induces TLR4-mediated TNF production that contributes to the initiation of cardiovascular shock [25, 26] and has been implicated in a wide range of inflammatory conditions [27].”
BackgroundLing, M. T., Tu, W., Han, Y., Mao, H., Chong, W. P., Guan, J. Z., Liu, M., Lam, K. T., Law, H., Peiris, M. J. S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir691 · Cited by 53
“Excessive production of TNF-a causes tissue injury, hemorrhagic shock, and death in mice [39, 40].”
BackgroundSan-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs
Lo, Y., Lin, Y., Yu, K., et al. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.03.015 · Cited by 53
Warr, G. A., Veitch, J. A., Walsh, A. W., et al. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.234 · Cited by 53
Platelet‐activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis
Hsueh, W., Caplan, M., Sun, X., Tan, X., MacKendrick, W., & González-Crussí, F. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13234.x · Cited by 52
Kadokami, T., McTiernan, C. F., Kubota, T., Frye, C. S., Bounoutas, G. S., Robbins, P. D., Watkins, S. C., & Feldman, A. M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2281 · Cited by 52
“Elevated plasma levels of TNF-a have been reported in a variety of cardiovascular diseases, including acute myocarditis (35), cardiac allograft rejection (8), myocardial infarction (36), and congestive heart failure (32, 34), as well as in endotoxemia (17, 51, 54).”
BackgroundSevransky, J., Shaked, G., Novogrodsky, A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119364 · Cited by 53
“Furthermore, therapies directed against endotoxin (10), TNFa (8), and IL-1 b”
BackgroundInfluentialWaage, A., & Aasen, A. O. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01416.x · Cited by 52
Dinarello, C. A. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60429-9 · Cited by 53
Suárez‐Fueyo, A., Rojas, J. M., Cariaga-Martínez, A. E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400350 · Cited by 52
HMGB1 in the Immunology of Sepsis (Not Septic Shock) and Arthritis
Czura, C. J., Yang, H., Amella, C. A., & Tracey, K. J. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)84005-7 · Cited by 52
Self-citationNon-haemorrhagic obstetric shock
Thomson, A. J., & Greer, I. A. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.1999.0061 · Cited by 52
Alcohol, Tumor Necrosis Factor, and Tuberculosis
Nelson, S., Mason, C. M., Bagby, G. J., & Summer, W. R. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01467.x · Cited by 52
Pirfenidone Blocks the In Vitro and In Vivo Effects of Staphylococcal Enterotoxin B
Hale, M. L., Margolin, S. B., Krakauer, T., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.2989-2994.2002 · Cited by 52
“Previous investigations have shown that antibodies recognizing TNF- decrease symptoms associated with toxic shock (30, 43).”
BackgroundGram-Negative Bacterial Sepsis and Sepsis Syndrome
Dunn, D. L. (1994) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)46333-4 · Cited by 52
Barry, M. C., Kelly, C. J., Burke, P., Sheehan, S., Redmond, H. P., & Bouchier‐Hayes, D. (1997) · British journal of surgery · doi:10.1002/bjs.1800840422 · Cited by 50
Bemelmans, M. H. A., Gouma, D. J., Greve, J. W. M., et al. (1993) · British journal of surgery · doi:10.1002/bjs.1800800845 · Cited by 52
Cytokine mediators of septic infections in the normal and granulocytopenic host
Waage, A., & Steinshamn, S. (1993) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1993.tb00156.x · Cited by 52
van der Meer, J. W. M. (1989) · Biotherapy · doi:10.1007/bf02170132 · Cited by 52
“IL-1 contribute to death from infection [25, 31, 32 ].”
BackgroundTNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction
Hauwermeiren, F. V., Vandenbroucke, R. E., Grine, L., Lodens, S., Wonterghem, E. V., Rycke, R. M. D., Geest, N. D., Hassan, B. A., & Libert, C. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.112 · Cited by 52
Tsuji, E., Hiki, N., Nomura, S., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11196 · Cited by 51
Antibiotic‐Induced Endotoxin Release from Bacteria and Its Clinical Significance
Kirikae, T., Nakano, M., & Morrison, D. C. (1997) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1997.tb01203.x · Cited by 52
Edmunds, N. J., Lal, H., & Woodward, B. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702294 · Cited by 51
Han, S. H., Kim, J. H., Seo, H. S., Martin, M. H., Chung, G., Michalek, S. M., & Nahm, M. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.573 · Cited by 51
“Host factors associated with multiorgan dysfunction include increased levels of proinflammatory cytokines such as TNF-, IL-1, IL-6, and IL-8 (3), and glycerophospholipids (4) such as platelet-activating factor (PAF).3 TNF- has been labeled “the hub of the cytokine network” (3) because it is sufficient to cause septic…”
BackgroundFasano, M. B., Cousart, S. L., Neal, S., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115454 · Cited by 51
Tumor necrosis factor-α in macrophages of heart, liver, kidney, and in the pituitary gland
Arras, M., Höche, A., Bohle, R. M., Eckert, P., Riedel, W., & Schaper, J. (1996) · Cell and Tissue Research · doi:10.1007/s004410050618 · Cited by 51
“This has been confirmed by Tracey et al. (1987) and Mathison et al. (1988).”
BackgroundTumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus
Haagmans, B. L., Stals, F. S., van der Meide, P. H., Bruggeman, C. A., Horzinek, M. C., & Schijns, V. E. C. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2297-2304.1994 · Cited by 51
Sepsis, Signals, and Surgical Sequelae (A Hypothesis)
MICHIE, H. R. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410160119023 · Cited by 51
Lau, A. S. Y., & Livesey, J. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114231 · Cited by 51
Mancini, F., Toro, C. M., Mabilia, M., Giannangeli, M., Pinza, M., & Milanese, C. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00150-1 · Cited by 50
Romero, R. J., Kadar, N. R., Vaisbuch, E., & Hassan, S. S. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00823.x · Cited by 48
Protective Effects of Polydatin on Septic Lung Injury in Mice via Upregulation of HO-1
Li, X., Gong, X., Zhang, L., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/354087 · Cited by 50
Mast Cell Stabilization Improves Survival by Preventing Apoptosis in Sepsis
Ramos, L., Peña, G., Cai, B., Deitch, E. A., & Ulloa, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000273 · Cited by 51
“A classical example is that anti-TNF therapies can prevent sepsis in the early stages when the treatment is started before the challenge (41), but these approaches failed in clinical trials, because they are ineffectivewhen administered after the septic challenge (4, 42, 43).”
BackgroundGH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia
Granado, M., Martı́n, A. I., López-Menduiña, M., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2007 · Cited by 50
Gl�ck, T., & Opal, S. M. (2004) · Drugs · doi:10.2165/00003495-200464080-00004 · Cited by 50
Meng, X., Ao, L., Meldrum, D. R., Cain, B. S., Shames, B. D., Selzman, C. H., Banerjee, A. M., & Harken, A. H. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.2.r502 · Cited by 50
The physiology of nutritional assessment and therapy in protein-calorie malnutrition.
McMahon, M., & Bristrian, B. R. (1990) · Disease-a-month : DM · doi:10.1016/0011-5029(90)90018-m · Cited by 45
Free radicals and septic shock in primates: The role of tumor necrosis factor
Lloyd, S. S., Chang, A. K., Taylor, F. B., Janzen, E. G., & McCay, P. B. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90020-u · Cited by 49
New strategies for combatting sepsis: the magic bullets missed the mark…but the search continues
Quezado, Z., Banks, S. M., & Natanson, C. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)88906-4 · Cited by 50
van Furth, R., van Zwet, T. L., Buisman, A., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.234 · Cited by 50
Silva, A. T., Appelmelk, B. J., Buurman, W. A., Bayston, K. F., & Cohen, J. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.2.454 · Cited by 49
“It has been shown that antibody to TNF protects mice from endotoxin-induced injury [10] and baboons from Escherichia coli sepsis [11].”
BackgroundControl of Fecal Peritoneal Infection in Mice by Colony-Stimulating Factors
Barsig, J., Bundschuh, D. S., Härtung, T., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.4.790 · Cited by 50
Cuzzocrea, S., Mazzon, E., Dugo, L., et al. (2002) · Cytokine · doi:10.1006/cyto.2002.0883 · Cited by 49
DeBerge, M., Ely, K. H., & Enelow, R. I. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302729 · Cited by 48
Matrix metalloproteinases contribute to endotoxin and interleukin‐1β induced vascular dysfunction
Lalu, M. M., Cena, J., Chowdhury, R., Lam, A. P., & Schulz, R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706823 · Cited by 49
“…sepsis and endotoxaemia the initial inflammatory response due to LPS is largely mediated by proinflammatory cytokines (including interleukin-1b (IL-1b) (Hesse et al., 1988) and tumor necrosis factor-a (Tracey et al., 1986, 1987)) which increase the production of a number of downstream effectors.”
BackgroundNissinen, R., Leirisalo-Repo, M., Peltomaa, R., Palosuo, T., & Vaarala, O. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.008599 · Cited by 50
TNF-α disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin
Rotundo, R. F., Curtis, T. M., Shah, M. D., Gao, B., Mastrangelo, A. M., LaFlamme, S. E., & Saba, T. M. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00145.2000 · Cited by 49
“Tumor necrosis factor- (TNF- ), an inflammatory cytokine released from endotoxin-activated monocytes and macrophages sequestered in the lung microcirculation and interstitium during sepsis or lung inflammation, is believed to contribute to disruption of the lung vascular barrier leading to the increase in protein perm…”
BackgroundBernard, C., Szekely, B., Philip, I., Wollman, E. E., Payen, D. M., & Tedgui, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115664 · Cited by 48
LeMay, L. G., Vander, A. J., & Kluger, M. J. (1990) · Cytokine · doi:10.1016/1043-4666(90)90032-o · Cited by 49
Mancuso, G., Tomasello, F. F., von Hunolstein, C., et al. (1994) · Infection and Immunity · doi:10.1128/iai.62.7.2748-2753.1994 · Cited by 49
“These effects are clearly observed in sepsis models involving intravascular injection of endotoxin (5) or whole gram-positive (10) and gramnegative (10, 29, 36) bacteria.”
BackgroundChikanza, I. C., Roux-Lombard, P., DAYER, J.-M., & Panayi, G. S. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05941.x · Cited by 47
Elsasser, T. H., Fayer, R., Rumsey, T. S., et al. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119146 · Cited by 49
Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury
Daniel, R. M. (2005) · Frontiers in bioscience · doi:10.2741/1665 · Cited by 49
“The cytokines produced during an inflammatory response cause depression of cardiac function (46-48) and hence methods that block the inflammatory response may be protective (49-51).”
BackgroundHematopoietic Stem-Progenitor Cells Restore Immunoreactivity and Improve Survival in Late Sepsis
Brudecki, L. E., Ferguson, D. A., Yin, D., LeSage, G., McCall, C. E., & Gazzar, M. E. (2011) · Infection and Immunity · doi:10.1128/iai.05480-11 · Cited by 48
“Anti-inflammatory treatment modalities targeting inflammatory mediators and bacterial toxins during the acute phase of sepsis were often effective in animal models of sepsis (44, 57) but failed in human clinical trials (26, 27, 49).”
BackgroundKoppolu, P., Durvasula, S., Palaparthy, R., Rao, M., Sagar, V., Reddy, S. K., & Swapna, L. A. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.15.92.2326 · Cited by 48
“Investigators added to substantiate the link between sepsis and TNF by utilizing anti-TNF monoclonal antibodies to counteract the circulating TNF and thereby put off its adverse effects on cardiovascular system [10].”
BackgroundWagner, L. A., Brown, T. A., Gil, S. C. I., Frank, I., Carter, W., Tamura, R. N., & Wayner, E. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199908)29:08 · Cited by 25
Chung, H., Kang, M., Cho, C., Parvez, S., Park, C.-H., Kim, D., Oh, J., Kim, H., Shin, M., Hong, M., et al. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.912 · Cited by 48
Anti-Cytokine Therapies in Response to Systemic Infection
Dinarello, C. A. (2001) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.0022-202x.2001.00046.x · Cited by 47
Petricevich, V. L., & Peña, C. F. (2002) · Mediators of Inflammation · doi:10.1080/09622935020138811 · Cited by 48
“However, some coincidences or discrepancies were also observed in venom composition among several snakes and scorpions according to the age, sex, nutritional state and geographic regions where the animals were captured.(5,6) To minimize the experimental bias, mice strains were used to of Tityus serrulatus venom (TSV)…”
MethodDefects in Host Defense Mechanisms
van der Meer, J. W. M., & Kullberg, B. J. (2002) · Springer eBooks · doi:10.1007/0-306-47527-8_2 · Cited by 48
Alpha‐globulins suppress human leukocyte tumor necrosis factor secretion
Scuderi, P., Dorr, R. T., Liddil, J. D., Finley, P. R., Meltzer, P. S., Raitano, A. B., & Rybski, J. A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190523 · Cited by 48
Tumor Necrosis Factor and Interleukin 1 Appearance in Experimental Gram-negative Septic Shock
Busund, R. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410290067014 · Cited by 48
Banks, R. E., Evans, S., Alexander, D. J., et al. (1991) · Cytokine · doi:10.1016/1043-4666(91)90004-w · Cited by 48
Rothstein, J. L., Lint, T. F., & Schreiber, H. W. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.6.2007 · Cited by 48
Shin, H. S., Drysdale, B. E., Shin, M. L., Noble, P. W., Fisher, S. N., & Paznekas, W. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.2914 · Cited by 47
Cytokine–Ion Channel Interactions in Pulmonary Inflammation
Hamacher, J., Hadizamani, Y., Borgmann, M., Mohaupt, M. G., Männel, D. N., Moehrlen, U., Lucas, R., & Stammberger, U. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01644 · Cited by 48
“TNF − Disruption of the lung vascular barrier (236, 237)”
BackgroundThalidomide protects mice against LPS-induced shock
Moreira, A. L., Wang, J., Sarno, E. N., & Kaplan, G. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997001000010 · Cited by 47
Carrizo, G. J., Wu, R., Cui, X., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.05.017 · Cited by 47
Protective effect of Aloe vera on polymicrobial sepsis in mice
Yun, N., Lee, C.-H., & Lee, S. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.03.013 · Cited by 48
“These results were also supported by data from several other groups including Tracey et al. (1987).”
ResultZiegeler, S., Raddatz, A., Hoff, G., et al. (2006) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2006.01112.x · Cited by 47
“Although this seems to be valid for the regional defence against bacterial stimuli, in systemic infection, an antiinflammatory regimen can be beneficial (22).”
BackgroundIs pyruvate an endogenous anti-inflammatory molecule?
Das, U. N. (2006) · Nutrition · doi:10.1016/j.nut.2006.05.009 · Cited by 47
“Sudden overproduction of tumor necrosis factor-alpha; TNF- ) occurs in acute septic shock and triggers hypotenion, circulatory collapse, renal and hepatic failures, and idespread inflammation and injury [3,4].”
BackgroundTHE ROLE OF TUMOUR NECROSIS FACTOR-α IN THE PATHOGENESIS OF COMPLICATED FALCIPARUM MALARIA
Odeh, M. (2001) · Cytokine · doi:10.1006/cyto.2001.0845 · Cited by 47
Increased Release of Soluble Tumor Necrosis Factor Receptors Into Blood During Clinical Sepsis
Ertel, W. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420360120017 · Cited by 47
Raeburn, C. D., Calkins, C. M., Zimmerman, M. A., Song, Y., Ao, L., Banerjee, A. M., Meng, X., & Harken, A. H. (2001) · Surgery · doi:10.1067/msy.2001.116410 · Cited by 45
Tumor Necrosis Factor Activity Increases in the Early Response to Trauma
Ferguson, K. L., Taheri, P. A., Rodriguez, J., et al. (1997) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1997.tb03676.x · Cited by 47
Induction of Tumor Necrosis Factor- in Murine Candida albicans Infection
Allendoerfer, R., Magee, D. M., Smith, J. G., Bonewald, L. F., & Graybill, J. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1168 · Cited by 47
Nishimura, M., Uchida, S., Mitsunaga, S., Yahagi, Y., Nakajima, K., Tadokoro, K., & Juji, T. (1997) · Blood · doi:10.1182/blood.v89.4.1440 · Cited by 44
Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock
Mózes, T., Ben‐Efraim, S., Tak, C. A. M., et al. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90144-y · Cited by 47
The role of tumour necrosis factor‐α in acquired immunodeficiency syndrome
Odeh, M. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00278.x · Cited by 45
ARF6 Inhibition Stabilizes the Vasculature and Enhances Survival during Endotoxic Shock
Davis, C. T., Zhu, W., Gibson, C. C., Bowman-Kirigin, J. A., Sorensen, L. K., Jing, L., Sun, H., Navankasattusas, S., & Li, D. Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400309 · Cited by 42
Obiri, D. D., & Osafo, N. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.05.047 · Cited by 45
“Tumour necrosis factor alpha, TNFα, a cytokine produced by macrophages during septic shock is one of the endogenous mediators that cause cardiovascular injury and death (Tracey et al., 1986, 1987).”
BackgroundPérez, L., Vallejos, A., Echeverría, C., Varela, D., Cabello‐Verrugio, C., & Simón, F. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0151-3 · Cited by 46
Utsunomiya, T., Chavali, S. R., Zhong, W. W., et al. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.804 · Cited by 46
“Dietary PUFAs can influence the production of cytokines (22, 23), and overproduction of TNF- is associated with an increase in mortality during sepsis (24, 25).”
BackgroundCurrent status of Interleukin-2 therapy in cancer
Tartour, É., Mathiot, C., & Fridman, W. H. (1992) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(92)90005-r · Cited by 46
Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia
Bernhagen, J., Calandra, T., Cerami, A., & Bucala, R. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90111-h · Cited by 46
Self-citationLead enhances lipopolysaccharide and tumor necrosis factor liver injury.
Honchel, R., Marsano, L. S., Cohen, D. A., Shedlofsky, S. I., & McClain, C. J. (1991) · PubMed · Cited by 46
Continuing Challenges of Sepsis Research
Crowther, M. (2001) · JAMA · doi:10.1001/jama.286.15.1894 · Cited by 46
LUNG-LIVER INTERACTIONS IN SEPSIS AND MULTIPLE ORGAN FAILURE SYNDROME
Matuschak, G. M. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70300-2 · Cited by 43
Modares, N. F., Hendrikse, L. D., Smith, L. K., Paul, M. S., Haight, J., Luo, P., Liu, S., Fortin, J., Tong, F. K., Wakeham, A. C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.002 · Cited by 29
van der Poll, T., Endert, E., Coyle, S. M., Agosti, J. M., & Lowry, S. F. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.2.r357 · Cited by 27
“Endogenous TNF has been implicated as an important mediator of LPS-induced host responses (26, 29, 30).”
BackgroundSelf-citationTherapy with antibody to tumor necrosis factor in sepsis
Pennington, J. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.supplement_2.s515 · Cited by 26
“[25] can protect against sepsis due to either gram-positive or gram-negative bacteria.”
BackgroundInfluential
Metadata
- Authors
- Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A.
- Affiliations
- Cornell University (US)
- Rockefeller University (US)
- Venue
- Nature
- Published
- 1987-12
- Volume
- 330
- Issue
- 6149
- Pages
- 662-664
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2038434279
- Cited by
- 2,448
- References
- 1
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 17 · 2022: 13 · 2021: 24 · 2020: 24 · 2019: 32 · 2018: 31 · 2017: 24 · 2016: 40 · 2015: 33 · 2014: 44 · 2013: 43 · 2012: 46
- FWCI
- 95.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TNF-α, septic shock, bacteremia, Escherichia coli, passive immunization, neutralizing monoclonal antibodies, F(ab')2 fragments, endotoxic shock, organ failure, renal failure, respiratory failure, stress hormones, baboons, sepsis treatment
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Pressure, Cardiac Output, Catecholamines, Glucagon, Immunization, Passive, Immunologic Techniques, Leukocyte Count, Papio, Shock, Septic, Tumor Necrosis Factor-alpha, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review